thanks for sharing this longreach. It’s a shame that some of this detail wasn’t included in the release. It at least restores some confidence in management and the process. They should maybe just work on their comm
it’s just an annoying, slow climb back with the share price
Ann: Update on Submission of Final Module to FDA, page-21
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
-0.005(0.50%) |
Mkt cap ! $306.5M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.00 | 97.5¢ | $124.6K | 126.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10527 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 15588 | 2 |
View Market Depth
| Last trade - 15.58pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.01 |
Change
-0.005 ( 1.01 %) |
||||
| Open | High | Low | Volume | ||
| $1.00 | $1.01 | 98.0¢ | 40869 | ||
| Last updated 15.58pm 16/05/2024 ? | |||||
| EBR (ASX) Chart |